...
【24h】

A prescription fraud detection model

机译:处方欺诈检测模型

获取原文
获取原文并翻译 | 示例

摘要

Prescription fraud is a main problem that causes substantial monetary loss in health care systems. We aimed to develop a model for detecting cases of prescription fraud and test it on real world data from a large multi-center medical prescription database. Conventionally, prescription fraud detection is conducted on random samples by human experts. However, the samples might be misleading and manual detection is costly. We propose a novel distance based on data-mining approach for assessing the fraudulent risk of prescriptions regarding cross-features. Final tests have been conducted on adult cardiac surgery database. The results obtained from experiments reveal that the proposed model works considerably well with a true positive rate of 77.4% and a false positive rate of 6% for the fraudulent medical prescriptions. The proposed model has the potential advantages including on-line risk prediction for prescription fraud, off-line analysis of high-risk prescriptions by human experts, and self-learning ability by regular updates of the integrative data sets. We conclude that incorporating such a system in health authorities, social security agencies and insurance companies would improve efficiency of internal review to ensure compliance with the law, and radically decrease human-expert auditing costs.
机译:处方欺诈是导致医疗保健系统大量金钱损失的主要问题。我们旨在开发一种用于检测处方欺诈案件的模型,并根据大型多中心医疗处方数据库中的实际数据对其进行测试。传统上,处方欺诈检测是由人类专家对随机样本进行的。但是,这些样品可能会产生误导,并且手动检测成本很高。我们提出了一种基于数据挖掘方法的新颖距离,用于评估关于跨功能处方的欺诈风险。已在成人心脏手术数据库上进行了最终测试。从实验中获得的结果表明,对于欺诈性医疗处方,该模型的真实阳性率为77.4%,虚假阳性率为6%,效果很好。该模型具有潜在的优势,包括处方欺诈的在线风险预测,人类专家对高风险处方的离线分析以及通过定期更新集成数据集的自我学习能力。我们得出的结论是,将这样的系统并入卫生当局,社会保障机构和保险公司将提高内部审查的效率,以确保遵守法律,并从根本上降低人工审计的成本。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号